Skip to content
★ Sign in to follow
IA

Investor AB

Related company / holding
Nasdaq, Inc.Ista Pharmaceuticals IncAchillion Pharmaceuticals IncTangoe IncGreenway Medical Technologies IncAgile Therapeutics Inc
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
92
Companies
6
▲ Purchases (23 ops.)
€57.8M
▼ Sales (55 ops.)
€6.4M

Latest filing published 13 Feb 2026 for NASDAQ, INC., €13.3M.

Filing timeline

BuySale
Investor AB

Insider track record

Disclosed buys
23
Disclosed sells
55
Signal history

No signal scores available.

Closed purchases

Market purchases
23
Positive at T+90
100%
Median T+90
+12.2%

Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 13 Feb 2026 · 268 days ago · €13.3M
    +28.7%
    Entry US$80.24 · Close 22 Oct 2026 US$103.30
  • Filed 25 May 2012 · 5280 days ago · €1.7M
    +41.6%
    Entry US$7.41 · Close at T+365 US$10.49
  • Filed 23 May 2012 · 5282 days ago · €684k
    +42.7%
    Entry US$7.35 · Close at T+365 US$10.49
  • Filed 16 May 2012 · 5289 days ago · €5.5M
    +42.5%
    Entry US$7.33 · Close at T+365 US$10.45
  • Filed 11 Aug 2011 · 5568 days ago · €2.3M
    -1.0%
    Entry US$7.87 · Close at T+365 US$7.79

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Investor AB: trading record in brief

Investor AB is a declared insider at 6 companies; the most frequent names are Ista Pharmaceuticals Inc, Achillion Pharmaceuticals Inc and Nasdaq, Inc. Between 9 February 2007 and 13 February 2026, the trades on record add up to 92 filings.

The open-market side counts 23 purchases for €57.8M alongside 55 sales for €6.4M. Netting one side against the other leaves €51.4M of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants. In 2026 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €1.6M. For 10 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +12.2%. These figures describe past trades and do not predict future prices.

Most recently, on 13 February 2026, the filings show an open-market purchase worth €13.3M in Nasdaq, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Investor AB

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations75 total
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    16M USD10SEC
    200,000 shares@ US$79.1752100.0% of flowCommon StockSEC:0001193125-26-051227:0
    Canonical exit: 14 May 2026 (T+90)
  • ▲
    Related company / holdingExecutivesAgile Therapeutics Inc
    15M USD0SEC
    2,509,949 shares@ US$6.00Common Stock, par value $0.0001 per shareSEC:0000905718-14-000315:0
    Canonical exit: 27 Aug 2014 (T+90)
  • ▲
    Related company / holdingExecutivesAgile Therapeutics Inc
    6M USD0SEC
    1,000,000 shares@ US$6.00Common Stock, par value $0.0001 per shareSEC:0000905718-14-000303:0
    Canonical exit: 20 Aug 2014 (T+90)
  • ●
    Related company / holdingExecutivesGreenway Medical Technologies Inc
    100M USD0SEC
    4,922,009 shares@ US$20.35Common StockSEC:0001140361-13-040546:0
  • ●
    Related company / holdingExecutivesGreenway Medical Technologies Inc
    43M USD0SEC
    2,109,431 shares@ US$20.35Common StockSEC:0001140361-13-040546:1
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    2M USD0SEC
    100,000 shares@ US$21.709Common StockSEC:0001104659-12-040006:0
    Canonical exit: 21 Aug 2012 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    876,008 USD0SEC
    40,000 shares@ US$21.9002Common StockSEC:0001104659-12-039437:0
    Canonical exit: 19 Aug 2012 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    7M USD0SEC
    300,000 shares@ US$23.5345Common StockSEC:0001104659-12-037722:0
    Canonical exit: 12 Aug 2012 (T+90)
  • ●
    Related company / holdingExecutivesGreenway Medical Technologies Inc
    0SEC
    2,735,526 sharesCommon StockSEC:0001188112-12-000335:0
  • ●
    Related company / holdingExecutivesGreenway Medical Technologies Inc
    0SEC
    951,188 sharesCommon StockSEC:0001188112-12-000335:1
  • ●
    Related company / holdingExecutivesGreenway Medical Technologies Inc
    0SEC
    1,172,368 sharesCommon StockSEC:0001188112-12-000335:2
  • ●
    Related company / holdingExecutivesGreenway Medical Technologies Inc
    0SEC
    407,652 sharesCommon StockSEC:0001188112-12-000335:3
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    4M USD0SEC
    200,000 shares@ US$21.1323Common StockSEC:0001104659-11-046078:0
    Canonical exit: 7 Nov 2011 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    3M USD0SEC
    150,000 shares@ US$21.6847Common StockSEC:0001104659-11-046078:1
    Canonical exit: 8 Nov 2011 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    5M USD0SEC
    200,000 shares@ US$22.7464Common StockSEC:0001104659-11-045243:0
    Canonical exit: 3 Nov 2011 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    5M USD0SEC
    200,000 shares@ US$23.585Common StockSEC:0001104659-11-043765:0
    Canonical exit: 31 Oct 2011 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    2M USD0SEC
    100,000 shares@ US$23.0846Common StockSEC:0001104659-11-043765:1
    Canonical exit: 1 Nov 2011 (T+90)
  • ▲
    Related company / holdingExecutivesNasdaq, Inc.
    2M USD0SEC
    100,000 shares@ US$22.8523Common StockSEC:0001104659-11-043765:2
    Canonical exit: 2 Nov 2011 (T+90)
  • ▼
    Related company / holdingExecutivesTangoe Inc
    1M USD0SEC
    132,361 shares@ US$9.30Common Stock, par value $0.0001 per shareSEC:0001179110-11-011551:0
  • ▼
    Related company / holdingExecutivesAchillion Pharmaceuticals Inc
    179,732 USD0SEC
    56,000 shares@ US$3.2095Common StockSEC:0001181431-10-001309:0
  • ▼
    Related company / holdingExecutivesAchillion Pharmaceuticals Inc
    125,812 USD0SEC
    39,200 shares@ US$3.2095Common StockSEC:0001181431-10-001309:1
  • ▼
    Related company / holdingExecutivesAchillion Pharmaceuticals Inc
    135,157 USD0SEC
    42,446 shares@ US$3.1842Common StockSEC:0001181431-09-059205:0
  • ▼
    Related company / holdingExecutivesAchillion Pharmaceuticals Inc
    94,609 USD0SEC
    29,712 shares@ US$3.1842Common StockSEC:0001181431-09-059205:1
  • ▼
    Related company / holdingExecutivesAchillion Pharmaceuticals Inc
    332,325 USD0SEC
    105,500 shares@ US$3.15Common StockSEC:0001181431-09-059205:2
  • ▼
    Related company / holdingExecutivesAchillion Pharmaceuticals Inc
    232,628 USD0SEC
    73,850 shares@ US$3.15Common StockSEC:0001181431-09-059205:3

25 of 75 declarations